OSUR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSUR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. OraSure Technologies's annualized positive value of Interest Expense for the quarter that ended in Mar. 2024 was $0.0 Mil. OraSure Technologies's average total debt for the quarter that ended in Mar. 2024 was $13.2 Mil. Therefore, OraSure Technologies's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 was 0.00%.
The historical data trend for OraSure Technologies's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Effective Interest Rate on Debt % | Get a 7-Day Free Trial | - | - | - | - | - |
OraSure Technologies Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Effective Interest Rate on Debt % | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Effective Interest Rate on Debt % falls into.
OraSure Technologies's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as
Effective Interest Rate on Debt % | ||||||
= | -1 * Interest Expense | / | ( (Total Debt (A: Dec. 2022 ) | + | Total Debt (A: Dec. 2023 )) | / count ) |
= | -1 * 0 | / | ( (12.547 | + | 13.504) | / 2 ) |
= | -1 * 0 | / | 13.0255 | |||
= | 0.00 % |
where
Total Debt (A: Dec. 2022 ) | |||
= | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
= | 9.604 | + | 2.943 |
= | 12.547 |
Total Debt (A: Dec. 2023 ) | |||
= | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
= | 11.388 | + | 2.116 |
= | 13.504 |
OraSure Technologies's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 is calculated as
Effective Interest Rate on Debt % | ||||||
= | -1 * Interest Expense | / | ( (Total Debt (Q: Dec. 2023 ) | + | Total Debt (Q: Mar. 2024 )) | / count ) |
= | -1 * 0 | / | ( (13.504 | + | 12.99) | / 2 ) |
= | -1 * 0 | / | 13.247 | |||
= | 0.00 % |
where
Total Debt (Q: Dec. 2023 ) | |||
= | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
= | 11.388 | + | 2.116 |
= | 13.504 |
Total Debt (Q: Mar. 2024 ) | |||
= | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
= | 10.88 | + | 2.11 |
= | 12.99 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.
OraSure Technologies (NAS:OSUR) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Thank you for viewing the detailed overview of OraSure Technologies's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
Kathleen Gallagher Weber | officer: Chief Product Officer | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Michele Marie Miller | officer: VP, Finance and Controller | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Robert W. Mcmahon | director | 250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
Kenneth J Mcgrath | officer: Chief Financial Officer | C/O ORASURE TECHNOLOGIES, INC., 220 E. FIRST STREET, BETHLEHEM PA 18015 |
Ronny B Lancaster | director | ORASURE TECHNOLOGIES INC, 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Mara G. Aspinall | director | 7381 NORTH MOON SPIRIT LANE, TUCSON AZ 85718 |
Nancy J Gagliano | director | 33 GRANITE WAY, GRANTHAM NH 03753 |
Michael Celano | director | 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Manner Carrie Eglinton | director, officer: President & CEO | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Scott Gleason | officer: Interim CFO/SVP IR | 1809 SOUTH 2500 EAST, SALT LAKE CITY UT 84108 |
Eamonn P Hobbs | director | C/O DELCATH SYSTEMS, INC., 600 FIFTH AVENUE, NEW YORK NY 10020 |
Anne Clem Whitaker | director | 109 BRIERY BRANCH COURT, MORRISVILLE NC 27560 |
James A Datin | director | 21 ESTATES DRIVE, DOYLESTOWN PA 18901 |
Lelio Marmora | director | 64 RUE DE VESENEX, DIVONNE LES BAINS I0 01220 |
Lisa Nibauer | officer: President of Diagnostics | 1 CRESENT PLACE, SHORT HILLS NJ 07078 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-02-2022
By Value_Insider Value_Insider • 11-01-2022
By GuruFocusNews GuruFocusNews • 06-12-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By sperokesalga sperokesalga • 06-13-2023
By Value_Insider Value_Insider • 11-02-2022
By Value_Insider Value_Insider • 11-03-2022
By GuruFocusNews GuruFocusNews • 07-04-2022
By PurpleRose PurpleRose • 07-12-2022
By PurpleRose PurpleRose • 07-14-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.